Diamonds and Dogs
Gilead (GILD) having a good a day. The HIV drug maker is up 11% to a three year high following earnings. Gilead easily beat estimates as sales fell 5%. Covid treatment declined 52% on lower Covid hospitalizations and less severe infections. However, their cancer drug sales surged 79%. Gilead was able to raise guidance which was a positive. Things are looking up at Gilead.
Another tech stock takes a hit. Amazon (AMZN) is down 11% to a two and a half year low, nearly falling below the trillion dollar market cap following lackluster earnings, a cautious view of the holiday season and lower cloud sales. Amazon said they will tighten their belt, including pausing hiring in certain businesses and winding down products and services until things rebound.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.